课题基金 / 基金详情

Identification of Methylated Genes in Chronic Lymphocytic Leukemia

Identification of Methylated Genes in Chronic Lymphocytic Leukemia
慢性淋巴细胞白血病甲基化基因的鉴定
批准号:
6986001
负责人:
CHRISTOPH PLASS
金额:
$21.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2011-06-30

项目摘要

项目成果

CHRISTOPH PLASS的其他基金

相似基金

相关文献

中文摘要
翻译
表观遗传学变化,包括DNA甲基化,是人类恶性肿瘤的常见发现。研究领域 慢性淋巴细胞白血病(CLL)关注的是促进细胞凋亡受损的基因缺失,但 到目前为止,发现的基因很少。在初步研究中,我们使用了限制标志 基因组扫描(RLGS),一种允许检测DNA改变的二维凝胶电泳 甲基化模式,以研究10个CLL患者样本中的甲基化。我们的结果有力地表明,DNA 甲基化通过基因沉默在CLL的发病机制中起重要作用。具体来说,我们 患者样本中异常甲基化的数量显著变化,范围为2.5-8.1% 与正常B细胞相比。充分确定甲基化在慢性淋巴细胞性白血病中的作用并利用这些变化 在临床上,我们建议进行更详细的研究,概述如下。我们对这个项目的假设是DNA 甲基化在慢性淋巴细胞性白血病的发生和发展中起着重要作用。在具体目标1中,RLGS将 适用于100例不同基因型的慢性淋巴细胞性白血病患者。CLL患者样本的RLGS图谱将进行比较 用CD19+的正常B淋巴细胞鉴定CLL特异的新的CLL甲基化序列。在……里面 此外,还将比较有利和不利基因之间的甲基化模式,以确定 在特定目标2.在特定目标2中,我们计划克隆成 使用基因组文库从Aim 1中鉴定出多达200个新的甲基化序列,这将指导 寻找新的CLL抑癌基因。此外,我们建议进行实验,以执行 慢性淋巴细胞性白血病DNA甲基化模式的生物统计学评价。在目标3中,这些基因将在一个 从国家合作肿瘤学小组获得的大量CLL患者样本,结果将是 与治疗反应、无进展生存期和总生存期相关。在具体目标4中,小说 候选癌症基因DAPK1、ID4和DERMO1的表达会因DNA甲基化而改变 为了确定CLL的发病机制和进展的潜在重要性,对其进行了更详细的研究。
英文摘要
Epigenetic changes, including DNA methylation, are a common finding in human malignancies. Research in chronic lymphocytic leukemia (CLL) has focused on genetic deletions that promote impaired apoptosis, but to date very few genes have been identified. In preliminary studies we have utilized Restriction Landmark Genomic Scanning (RLGS), a two-dimensional gel electrophoresis that allows detection of altered DNA methylation patterns, to study methylation in ten CLL patient samples. Our results strongly indicate that DNA methylation, via gene silencing, contributes significantly to the pathogenesis of CLL. Specifically, we demonstrated marked variation in the amount of aberrant methylation in patient samples ranging from 2.5-8.1% as compared to normal B cells. To fully establish the role of methylation in CLL and to exploit these alterations in the clinic, we propose more detailed studies outlined below. Our hypothesis for this Project is that DNA methylation contributes significantly to the development and progression of CLL. In Specific Aim 1, RLGS will be used on 100 CLL patients of different genotypes. RLGS profiles of CLL patients samples will be compared with CD19+ selected normal B-lymphocytes to identify novel CLL methylation sequences specific to CLL. In addition, methylation patterns between favorable and un-favorable genotypes will be compared to identify the most promising gene targets to pursue for investigation in Specific Aim 2. In Specific Aim 2, we plan to clone as many as 200 novel methylated sequences identified from aim 1 using genomic libraries that will guide the search for new tumor suppressor genes in CLL. Furthermore we propose experiments to perform a biostatistical evaluation of DNA methylation patterns in CLL. In aim 3 these genes will then be analyzed in a large cohort of CLL patient samples obtained from the national cooperative oncology groups, and results will be correlated with response to therapy, progression-free survival and overall survival. In Specific Aim 4, novel candidate cancer genes, DAPK1, ID4 and DERMO1, whose expression is altered by DNA methylation, will be studied in more detail in order to determine potential importance to the pathogenesis and progression of CLL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genotyping and Sequencing
  • 批准号:
    7613088
  • 项目类别:
  • 资助金额:
    $9.16万
  • 财政年份:
    2005
  • 负责人:
    CHRISTOPH PLASS
  • 依托单位:
DNA methylation as a diagnostic marker in AML
  • 批准号:
    6998912
  • 项目类别:
  • 资助金额:
    $28.84万
  • 财政年份:
    2002
  • 负责人:
    CHRISTOPH PLASS
  • 依托单位:
DNA methylation as a diagnostic marker in AML
  • 批准号:
    6417420
  • 项目类别:
  • 资助金额:
    $29.49万
  • 财政年份:
    2002
  • 负责人:
    CHRISTOPH PLASS
  • 依托单位:
DNA methylation as a diagnostic marker in AML
  • 批准号:
    6620434
  • 项目类别:
  • 资助金额:
    $29.54万
  • 财政年份:
    2002
  • 负责人:
    CHRISTOPH PLASS
  • 依托单位:
海外基金